Atlas Trials

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Clinical trial NCT05006469 · UNKNOWN

Trial details

NCT number
NCT05006469
Sponsor
Liao Aijun
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
BendamustineMultiple Myeloma
Start date
2021-06-01
Primary completion
2023-05-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.